Screener
Prime Medicine PRME PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses | 1,357 | 2,939 |
| Other current assets | 376 | 674 |
| Total current assets | 96,804 | 181,293 |
| Property and equipment, net | 17,077 | 20,572 |
| Operating lease right-of-use assets | 120,468 | 126,177 |
| Restricted cash | 13,691 | 13,691 |
| Other assets | 1,000 | 1,000 |
| Total assets | $249,040 | $342,733 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's PP&E (net)?
- Prime Medicine (PRME) reported PP&E (net) of $17.08M in Q2 2026.
- How has Prime Medicine's PP&E (net) changed year-over-year?
- Prime Medicine's PP&E (net) decreased by 28.3% year-over-year, from $23.83M to $17.08M.
- What is the long-term trend for Prime Medicine's PP&E (net)?
- Over 4 years (2021 to 2025), Prime Medicine's PP&E (net) has grown at a 42.9% compound annual growth rate (CAGR), from $4.93M to $20.57M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Prime Medicine's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude